Nwaichi et al.
2024
Recent advances and prospects on retarder application in oilwell cement: A review
YU51101A
(sh )
2004-05-12
Polimorfni oblici telmisartana, postupak za njihovo pripremanje i njihova primena za pripremanje leka
DK1222207T3
(da )
2008-03-17
C-peptid til forbedret fremstilling af insulin og insulinanaloge
HUP9801886A2
(hu )
1999-01-28
Eljárás megfelelően kapcsolódó cisztinhidakat tartalmazó inzulin-prekurzorok előállítására
TR200003583T2
(tr )
2001-05-21
Yeni 3-aril propiyonik asit türevleri ve benzerleri.
ES8801312A1
(es )
1987-12-16
Un procedimiento para preparar derivados de alanil-prolina.
Rubin et al.
1985
Fulminant hepatic failure caused by genital herpes in a healthy person
ATE116969T1
(de )
1995-01-15
Nmda-antagonisten.
GANGULY et al.
2001
Sensitivity of Salmonella typhi isolated from patients in Roorkee to antibiotics and two Unani drugs
Bhan et al.
1989
Quantitation and properties of fecal and upper small intestinal aerobic microflora in infants and young children with persistent diarrhea
GB1362743A
(en )
1974-08-07
Nonapeptides and a process for the manufacture thereof
DE1662162U
(de )
1953-08-27
Vorrichtung zum beleuchten von raeumen.
Speier
1970
Complications of rubella vaccination
GB547564A
(en )
1942-09-02
Improvements in and relating to preparations for the treatment of burns, lesions and the like
GB1414514A
(en )
1975-11-19
Sulphonyl ureas and process for preparing them
Siddall et al.
1931
THE BROMINE WATER TEST FOR PREGNANCY
ES2074555T3
(es )
1995-09-16
Preparados acuosos de colorante.
DE665431C
(de )
1938-09-24
Verfahren zur Herstellung von basischen Farbstoffen der Triphenylmethanreihe
DE1486330U
(enExample )
Nab et al.
1987
Drug points: Depression associated with tizanidine
ES2094850T3
(es )
1997-02-01
Nuevos derivados de isatinoxima, su preparacion y su utilizacion.
DEL0001445MA
(de )
1951-03-22
Lamellenstempel.
SU523880A1
(ru )
1976-08-05
В жущее
Birman et al.
1991
A study of oral mucosal lesions in geriatric patients
Fiala et al.
1991
Clinical benefits and recovery of delayed-type hypersensitivity in patients with AIDS-related complex treated with IMREG-1 or placebo